Exclusive-Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles
#Pfizer #BioNTech #COVID-19 vaccine #clinical trial #recruitment #study halt #US
📌 Key Takeaways
- Pfizer and BioNTech have paused their US COVID-19 vaccine study due to recruitment challenges.
- The halt is attributed to difficulties in enrolling enough participants for the trial.
- This decision may delay the development and potential approval of their updated vaccine.
- The companies are exploring alternative strategies to continue their research efforts.
🏷️ Themes
Vaccine Development, Clinical Trials
Entity Intersection Graph
No entity connections available yet for this article.